By Mark Tapscott | 09/16/14 06:15 PM
Officials in charge of Medicare Part B paid $132.9 million in dispensing and supplying fees for drugs and equipment used in certain cancer treatments, according to the Department of Health and Human Services Inspector General Daniel Levinson.
09/12/14 10:46 AM
INDIANAPOLIS (AP) — Eli Lilly and Co. said Friday its potential colorectal cancer drug Cyramza helped patients on chemotherapy with advanced cases of the disease survive longer than patients on chemotherapy alone. The Indianapolis company said patients treated with Cyramza and a chemotherapy in...
09/10/14 11:17 AM
COLUMBUS, Ohio (Legal Newsline) – The Ohio Supreme Court recently held that the medical doctor testifying on causation in a former smoker’s asbestos case must be a treating physician and must indicate that the smoking habit, alone, is insufficient to cause the asbestos-related disease for the...
09/04/14 05:45 PM
TRENTON, N.J. (AP) — Merck & Co. on Thursday won the first U.S. approval for a new kind of cancer drug with big advantages over chemotherapy and other older cancer treatments. The Food and Drug Administration said it has granted accelerated approval to Merck's Keytruda, for treating melanoma...
09/04/14 03:15 PM
PITTSBURGH (AP) — Health insurer Highmark Inc. has sued the University of Pittsburgh Medical Center claiming the hospital network has overbilled it by $300 million for cancer drugs since 2010. Highmark's lawsuit, filed late Wednesday, contends UPMC has been charging for chemotherapy treatments...
08/31/14 08:30 AM
ALBANY, N.Y. (AP) — A new report from the American Cancer Society says New York state needs to do more to prevent smoking. The Cancer Action Network at the American Cancer Society analyzed the state's efforts to combat cancer through screenings, tobacco taxes, smoking bans and restrictions on...
By Steve Chapman | 08/27/14 06:29 PM
The United States has been bombing ISIS in Iraq and may attack them in Syria; all of which may do more harm than good.
By Mark Flatten | 08/21/14 11:34 AM
An Indiana man faces an uncertain fate after warning signs went unnoticed in six years of VA medical screenings.
By Paul Bedard | 09/30/14
By Byron York | 09/29/14
By Becket Adams | 09/30/14
By Luke Rosiak | 09/29/14
By Philip Klein | 09/29/14